ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Stocks in news: RIL, PC Jeweller, Dr Reddy's, Enviro Infra Engineers, HDFC Life, SBI Life
Leading exchange BSE has revised the price band of Adani Total, Paytm, LIC, Jio Financial, Angel One, Zomato among 55 stocks to 10% with effect from November 29.
Announcement as on 29 November 2024

Dr Reddy's launches immuno-oncology drug Toripalimab in India for treating nasopharyngeal carcinoma
Dr. Reddy's Laboratories launched Zytorvi (Toripalimab), a novel immunotherapy drug for recurrent or metastatic nasopharyngeal carcinoma (NPC), a rare head and neck cancer. This marks India as the third country globally with access to this next-gen PD-1 in
Announcement as on 28 November 2024

Dr Reddy's launches novel cancer therapy Toripalimab in India
Dr. Reddy’s has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will be marketed as Zytorvi. It shows significant efficac
Announcement as on 28 November 2024

Dr Reddy's launches drug for neck, head cancer
Dr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This drug is for treating recurrent or metastatic nasopharyngeal carcinoma. It will be marketed under the name Zytorvi. Bef
Announcement as on 28 November 2024

Dr Reddy's Labs, Mankind Pharma riding on strong growth drivers
Indian pharmaceutical giants, Dr. Reddy's Labs and Mankind Pharma, reported impressive double-digit revenue growth in the September quarter. Dr. Reddy's achieved this milestone despite challenges in Europe and increased expenses, while Mankind Pharma thriv
Announcement as on 06 November 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.62
  • 12Day Average: 14.25
  • 20Day Average: 13.87
  • 50Day Average: 13.62
  • 100Day Average: 13.75
  • 150Day Average: 13.77
  • 200Day Average: 13.85

RDY Indicators & signals

Indicator MACD (12,26,9)

14.27, 13.96, 0.26
Indicator MACD is in positive zone

Indicator ADX (14)

3.45, 37.5, 35
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.61 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 0.99 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 0.94 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.48 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.03 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.28 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.87 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.15 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 0.9 times
18 Thu Jun 2026 13.29 13.20 to 13.36 1.06% 0.56 times
17 Wed Jun 2026 13.15 13.08 to 13.32 -1.13% 0.8 times
16 Tue Jun 2026 13.30 13.23 to 13.38 -0.23% 0.45 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top